Crossmark

Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine

Crossref DOI link: https://doi.org/10.1038/leu.2017.323

Published Online: 2017-11-06

Published Print: 2018-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Molenaar, R J

Pleyer, C

Radivoyevitch, T

Sidana, S

Godley, A

Advani, A S

Gerds, A T

Carraway, H E

Kalaycio, M

Nazha, A

Adelstein, D J

Nasr, C

Angelini, D

Maciejewski, J P

Majhail, N

Sekeres, M A

Mukherjee, S
License Information

Text and Data Mining valid from 2017-11-06
More Information

Article History

Received: 3 August 2017

Revised: 23 October 2017

Accepted: 26 October 2017

First Online: 6 November 2017

Competing interests

: The authors declare no conflict of interest.